SAB BIO
Pre-clinicalAt SAB BIO, our mission is to dramatically redefine what it means to be diagnosed with Type 1 Diabetes by developing a medicine to change the course of disease, not just treat symptoms.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $23M
About
At SAB BIO, our mission is to dramatically redefine what it means to be diagnosed with Type 1 Diabetes by developing a medicine to change the course of disease, not just treat symptoms.
AntibodiesBiologics
Funding History
2Total raised:$23M
Series A$20MNov 15, 2022
Seed$3MSep 15, 2020